8027EGP
- Active ingredient
- sodium zirconium cyclosilicate
- Form
- sachet
- Manufacturer
- astrazeneca > astrazeneca scientific office
- Route
- eff
Uses
Used for the treatment of hyperkalemia in adults.
Do not use if
No specific contraindications are listed in the prescribing information.
Side effects
The most common adverse effect is mild to moderate edema. Gastrointestinal effects and hypokalemia may occur.
Warnings
Not suitable for emergency treatment of life-threatening hyperkalemia. Monitor for edema and electrolyte disturbances.
How it works
A non-absorbed potassium binder that exchanges sodium and hydrogen for potassium in the gastrointestinal tract, increasing fecal potassium elimination.
Storage
Store at room temperature in the original packaging.
